decisionhealth Newsletters, Coder Pink Sheets - 2008 Issue 1 (January)
Tips on coding Avastin injections during the global of a procedure
Subscribe or sign in to view the full article.
Article Overview
This piece is aimed at ophthalmology coders, billing staff, and clinicians who need to understand how intravitreal drug injections are handled when performed during the global period of retinal surgery. It reviews general billing context, mentions relevant Medicare and ABN considerations, and includes an update on Avastin access and broader policy attention affecting ophthalmic use.
Why This Topic Matters
The article helps readers determine whether a retinal-surgery-related injection may be separately reportable and highlights why timing, payer policy, and drug availability can affect reimbursement and access.
Article Sections
-
Coding Avastin injections during the global period
Explains the billing scenario involving an intraocular injection during the global period of retinal surgery and discusses the general use of modifiers in that context.
-
Typical scenario
Presents an example involving retinal surgery, an ophthalmic injection, and a shared diagnosis to frame the coding question.
-
Update on Avastin
Summarizes broader developments involving Avastin availability, pharmaceutical access, and related attention from medical and government organizations.
What You Will Learn
- How the article frames billing for ophthalmic injections during a surgical global period
- Which general modifier concepts are discussed in relation to separate reporting
- How the article connects payer coverage concerns with off-label ophthalmic use
- What broader access and policy issues are mentioned for Avastin in eye care
Who Should Read This
- Ophthalmology coders
- Medical billing staff
- Retina practices
- Physicians and surgeons
- Revenue cycle professionals
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com